AstraZeneca aims for a full listing in New York, but remains headquartered in the United Kingdom.
Adrian Rusu
International
Foto: shutterstock.com/ro
Always see our news on Google
AstraZeneca announced on Monday that it intends to move to a direct listing of its shares on the New York Stock Exchange, in a move aimed at capitalizing on the high appetite of American investors, but emphasized that it will not leave London.
Sources
Gigantul farmaceutic european AstraZeneca vizează listare completă la New York
AstraZeneca vizează listare completă la New York, dar îşi reafirmă angajamentul faţă de Londra
UK plc can't afford to lose AstraZeneca to Wall Street
AstraZeneca's listing rejig spells long-term danger for London | Nils Pratley
AstraZeneca trece la listare directă pe bursa din New York, dar rămâne cu sediul în Marea Britanie
Latest News
20:34
Ilie Bolojan: "Romania needs a Government – this is as clear as it can be. The state of provisionality has lasted too long."
20:32
Romania inaugurates the new embassy headquarters in Riga, marking 105 years of diplomatic relations with Latvia.
20:12
Ilie Bolojan stated that he does not regret the meeting with the president of the Constitutional Court, Simina Tănăsescu: "There is nothing secret or of another nature, and it was explained what it is about."
20:05
President of Serbia Aleksandar Vučić accuses the UN tribunal of "uncivilized behavior" after the death of Ratko Mladić
19:55
Ilie Bolojan: Investments of 290 million euros for energy efficiency in industry. Seven projects approved.
See more news
NEWS ON THE SAME TOPICS
International
AstraZeneca, negotiations with Bristol Myers Squibb for a possible merger that could create a 400 billion dollar group
International
AstraZeneca announced the failure of a drug for a rare heart condition, causing a 9% drop in the company's shares.
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
